[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 23.23.50.247. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Correspondence
August 1999

Effectiveness of Photopheresis in Sézary Syndrome—Reply

Author Affiliations

Not Available

Arch Dermatol. 1999;135(8):996. doi:10-1001/pubs.Arch Dermatol.-ISSN-0003-987x-135-8-dlt0899

In reply

We are delighted that so many different groups from North America and Europe agree with our conclusions that a randomized trial would be desirable to assess the efficacy of photopheresis in CTCL.1 Unfortunately, our recent efforts to establish an international trial have been unsuccessful. Our intention was to report our experience of photopheresis in a large series of patients with SS in which the diagnosis has been supported by molecular analysis of T-cell receptor genes. We have also compared the response data and median survival figures in this group with those results in patients for whom photopheresis was not available.

First Page Preview View Large
First page PDF preview
First page PDF preview
×